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A Novel Recessive Missense Mutation in KRT14 Reveals Striking
Phenotypic Heterogeneity in Epidermolysis Bullosa Simplex
To the Editor:
Epidermolysis bullosa simplex (EBS) is the most common
form of epidermolysis bullosa with an estimated prevalence
of 1:200,000 (Pfendner et al, 2001). The disease is charac-
terized by intraepidermal blistering resulting in most cases
from mutations in cytokeratin genes 5 (KRT5) or 14 (KRT14)
(Irvine and McLean, 1999). Extensive studies in the US and
Europe have shown that EBS is almost always inherited in
an autosomal dominant fashion. In the vast majority of the
cases, the disease is thought to be caused by dominant-
negative missense mutations, which impair the ability
of KRT5 or KRT14 to interact as obligatory heterodimers
during the formation of the cell cytoskeleton (Fuchs, 1999),
resulting in diminished keratinocyte capacity to resist me-
chanical stress, and leading to cell cytolysis and blister
formation upon exposure of the skin to friction forces. Gen-
otype–phenotype correlation analysis of these data revea-
led that mutations affecting conserved sequences located
at both ends of the central a-helical rod of KRT5 or KRT14
are associated with a more severe disease course (Irvine
and McLean, 1999). In recent years, a growing number of
exceptions to these rules have been reported (Cummins
et al, 2001; Liovic et al, 2001; Ciubutaro et al, 2003).
In this study, we ascertained a large Israeli family of Arab
Moslem origin, which presents a phenotype contradicting
several molecular epidemiological features reported in the
literature to be characteristic of EBS, namely autosomal
dominant inheritance and correlation between mutation lo-
cation and disease severity (Irvine and McLean, 1999). The
proband, a 4-y-old girl, was born at term after an uneventful
pregnancy. Blisters were observed over her feet and hands
a few days after birth. The disease was aggravated during
the summer and blisters were scarce during the winter. The
parents noticed significant improvement with fewer lesions
appearing for shorter periods of time as the patient grew up.
At the age of 4 y, the patient was virtually free of symptoms,
and blisters could be elicitated only after vigorous rubbing
of the skin (Fig 1a). We also examined the proband’s cousin,
aged 5 y. She had been similarly affected with acral blis-
tering since infancy, but at the age of 5 y developed blisters
only after strenuous physical effort. In both cases, parents
were asymptomatic. The family pedigree suggests an au-
tosomal recessive mode of inheritance. The parents report-
ed that similar symptoms (acral blistering during the first
years of life) had been observed in additional members of
the family (Fig 1b), but these individuals declined from par-
ticipating in our study and were not examined. Despite the
early onset of the disease, the clinical findings and the
course of the disease were consistent with a diagnosis of
Weber–Cokayne EBS.
We obtained written and informed consent of all partic-
ipants or their legal guardian according to a protocol re-
viewed and approved by the local Helsinki Committee and
by the Committee for Genetic Studies of the Israeli Ministry
of Health. To confirm a clinical diagnosis of epidermolysis
bullosa Weber–Cockayne type, a skin biopsy was obtained.
Immunohistochemical staining of a lesional skin biopsy with
antibodies to collagen IV (Dako, Carpinteria, California) in-
dicated that the basement membrane was present at the
floor of the blister. An anti-pankeratin antibody (Dako) re-
vealed residual staining at the base of the blister (Fig 1c),
suggesting a diagnosis of EBS as detailed elsewhere (Pet-
ronius et al, 2003). To identify the molecular basis of the
disease in this family, we obtained blood samples from the
two patients and their parents. Genomic DNA was extracted
according to standard protocols. All exons and exon–intron
boundaries of KRT5 and KRT14 genes were PCR-amplified
as previously described (Ciubutaro et al, 2003). After gel-
purification, the resulting amplicons were directly se-
quenced. Mutation analysis revealed in both patients a
homozygous C ! T transition (C400T) resulting in the sub-
stitution of a cysteine for an arginine residue at position 134
(R134C) of the KRT14 amino acid sequence (Fig 1d). The
mutation was carried in a heterozygous state by all four
parents and was confirmed by bi-directional sequencing. No
polymorphic changes were identified in the patient; however,
individual 02003 carries T94A in a heterozygous state.
Recessive mutations causing EBS are considered to be
extremely rare (Ciubutaro et al, 2003). Out of 11 EBS-as-
sociated recessive mutations described worldwide, six re-
sulted in premature termination of translation and were
shown to cause absence of KRT14 expression, and four
were missense mutations (Hovnanian et al, 1993; Ciubutaro
et al, 2003; Lanschuetzer et al, 2003). Partial dominance of a
homozygous missense mutation in KRT14 has also been
previously described (Hu et al, 1997). This is the second
report of a fully recessive homozygous missense mutation
causing EBS. Interestingly, the first patients shown to carry
biallelic missense mutations in K14 also displayed a very
mild phenotype (Hovnanian et al, 1993).
R134C affects a highly conserved residue located in
the 1A domain of the central a-helical rod segment of
the KRT14 molecule (Conseq score¼ 9; http://conseq.
bioinfo.tau.ac.il/). In this case, it was shown to cause a
mild form of EBS in two affected cousins carrying this mu-
tation in a homozygous state. Surprisingly, a heterozygousAbbreviation: EBS, epidermolysis simplex bullosa
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mutation affecting the same codon, R134P, was previously
reported to cause a severe form of EBS (Rugg et al, 2000).
Two explanations may account for the contrasting clinical
consequences of two mutations affecting an identical co-
don. First, the degree to which KRT14 function is affected
by different changes of polarity, charge or structure can
obviously vary (Cummins et al, 2001; Ciubutaro et al, 2003).
In the case of both R134P and R134C, a positively charged
residue, arginine, is replaced by a polar uncharged residue,
cysteine, or proline. As demonstrated, however, in a recent
study (Smith et al, 2004), proline mutations result in marked
structural distortions of a-helices, which may explain the
more severe phenotype displayed by the patients carrying
R134P reported by Rugg et al (2000) as compared with the
present cases displaying R134C. Alternatively, the exist-
ence of modiying traits, as recently examplified in other
forms of epidermolysis bullosa (Bodemer et al, 2003), may
account for the varying phenotypic expression of the two
mutations. In summary, this study demonstrates that a
biallelic recessive mutation in KRT14 can cause a less se-
vere phenotype than a heterozygous mutation affecting the
same amino acid residue, adding to a growing body of ev-
idence which suggests that the relationship between phe-
notype and genetic pathology in EBS may be more complex
than initially thought.
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Figure 1
(a) A small blister is elicitated after rubbing of the proband’s big toe; (b) Pedigree of the family indicates autosomal recessive inheritance. Individuals
who were examined and from whom DNA was available are designated with a number. An arrow points to the proband; (c) A biopsy was obtained
from a blister and stained with an anti pan-keratin antibody as previously described (Petronius et al, 2003). The biopsy demonstrates an intra-
epidermal blister containing fibrin and erythrocytes. The base of the blister consists of immunoreactive remaining keratinocytes (immunoperoxidase,
scale bar¼ 50 mm); (d) Direct sequencing revealed a homozygous C ! T transition at position 400 of the KRT14 (cytokeratin gene 14) cDNA
sequence in patient 01002 (left panel). The father of patient 01002 is carrying the mutation in a heterozygous state (middle panel). The wild-type
sequence is given for comparison (right panel).
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